SUMY. Aug 11 (Interfax-Ukraine) – Kusum Pharm LLC (Sumy) intends to use the opportunities of import replacement to double production capacity of the Sumy plant in 2018 and 2019, the co-founder and Director General Rajeev Gupta has said.
“First partially and later fully we will switch over to production of medicines we now import from our plant in India to Sumy,” he told reporters during a recent visit of Indian Ambassador to Ukraine Manoj Kumar Bharti to Sumy.
Gupta said that the Sumy plant could start producing 50 more medicines, and their number would double.
He said that this year the company seeks to expand warehouses by 1,500 square meters, to 4,000 square meters and next year – to expand the administrative building and the quality control department. Then the expansion of production facilities will start in 2018.
Gupta said conditions for attracting investment has been improved by cutting bureaucratic red tape and offering tax incentives for innovation companies.
Kusum Pharm LLC was registered in 2005. Its founders and owners on a parity basis are Gupta and Russian citizen Vladimir Lukyanenko via Swiss Torberg Beteiligungen AG.
